BridgeBio Pharma, Inc.

SC US (TTGP), LTD. BBIO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,860,364

Value ($000)

142,299

Weight

1.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	142,299	1.0%	1,860,364	12/31/2025
2025 Q3	11/14/2025	96,627	0.6%	1,860,364	9/30/2025
2025 Q2	8/14/2025	80,331	0.6%	1,860,364	6/30/2025
2025 Q1	5/14/2025	64,313	0.6%	1,860,364	3/31/2025
2024 Q4	2/14/2025	51,048	0.4%	1,860,364	12/31/2024
2024 Q3	11/14/2024	47,365	0.3%	1,860,364	9/30/2024
2024 Q2	8/14/2024	47,123	0.4%	1,860,364	6/30/2024
2024 Q1	5/14/2024	57,522	0.4%	1,860,364	3/31/2024
2023 Q4	2/14/2024	75,103	0.6%	1,860,364	12/31/2023
2023 Q3	12/21/2023	49,058	0.5%	1,860,364	9/30/2023
2023 Q2	8/14/2023	31,998	0.3%	1,860,364	6/30/2023
2023 Q1	5/15/2023	30,845	0.4%	1,860,364	3/31/2023
2022 Q4	2/14/2023	14,176	0.2%	1,860,364	12/31/2022
2022 Q3	11/14/2022	18,492	0.2%	1,860,364	9/30/2022
2022 Q2	8/15/2022	16,892	0.2%	1,860,364	6/30/2022
2022 Q1	5/16/2022	18,883	0.1%	1,860,364	3/31/2022
2021 Q4	2/25/2022	31	0.2%	1,860,364	12/31/2021
2021 Q3	11/15/2021	87	0.5%	1,860,364	9/30/2021
2021 Q2	8/16/2021	113	0.7%	1,860,364	6/30/2021
2021 Q1	5/17/2021	157	0.9%	2,544,738	3/31/2021
2020 Q4	2/16/2021	181	1.1%	2,544,738	12/31/2020
2020 Q3	11/16/2020	95	0.9%	2,544,738	9/30/2020
2020 Q2	8/14/2020	82,984	4.9%	2,544,738	6/30/2020
2020 Q1	5/15/2020	73,797	5.7%	2,544,738	3/31/2020
2019 Q4	2/14/2020	89,193	3.8%	2,544,738	12/31/2019